John Paulson Acquires 1,156,640 Shares of Bausch Health Cos Inc. (NYSE:BHC) Stock

Key Points

• John Paulson, director of Bausch Health Cos Inc., made a significant acquisition of 1,156,640 shares at an average price of $6.88, raising his total ownership to approximately $247.3 million.
• The company's stock recently experienced a 2.5% increase in value, trading at $7.18, while its market cap stands at about $2.66 billion.
• Bausch Health's latest earnings report revealed an EPS of $0.90, missing estimates, while revenues exceeded expectations at $2.57 billion.

Bausch Health Cos Inc. (NYSE:BHC - Get Free Report) Director John Paulson purchased 1,156,640 shares of the firm's stock in a transaction that occurred on Tuesday, August 12th. The shares were bought at an average price of $6.88 per share, for a total transaction of $7,957,683.20. Following the acquisition, the director directly owned 35,948,342 shares in the company, valued at $247,324,592.96. This trade represents a 3.32% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.

John Paulson also recently made the following trade(s):

• On Thursday, August 14th, John Paulson acquired 34,721,118 shares of Bausch Health Cos stock. The shares were bought at an average price of $9.00 per share, with a total value of $312,490,062.00.
• On Wednesday, August 13th, John Paulson purchased 86,409 shares of Bausch Health Cos stock. The stock was acquired at an average cost of $7.06 per share, with a total value of $610,047.54.
• On Monday, August 11th, John Paulson purchased 2,000,000 shares of Bausch Health Cos stock. The shares were purchased at an average cost of $6.35 per share, with a total value of $12,700,000.00.
• On Friday, June 13th, John Paulson bought 3,564,059 shares of Bausch Health Cos stock. The shares were bought at an average cost of $5.94 per share, for a total transaction of $21,170,510.46.
• On Thursday, June 12th, John Paulson acquired 1,005,376 shares of Bausch Health Cos stock. The stock was acquired at an average price of $5.47 per share, for a total transaction of $5,499,406.72.
• On Wednesday, June 11th, John Paulson purchased 1,029,098 shares of Bausch Health Cos stock. The stock was acquired at an average cost of $5.24 per share, with a total value of $5,392,473.52.
• On Tuesday, June 10th, John Paulson acquired 754,134 shares of Bausch Health Cos stock. The stock was purchased at an average price of $5.05 per share, for a total transaction of $3,808,376.70.

Bausch Health Cos Trading Down 3.1%

BHC stock traded down $0.26 during mid-day trading on Monday, hitting $8.09. 1,422,923 shares of the company were exchanged, compared to its average volume of 2,691,043. Bausch Health Cos Inc. has a 12-month low of $4.25 and a 12-month high of $9.85. The firm has a market capitalization of $2.99 billion, a P/E ratio of 31.21 and a beta of 0.41. The business has a fifty day simple moving average of $6.38 and a 200-day simple moving average of $6.01. The company has a quick ratio of 0.98, a current ratio of 1.31 and a debt-to-equity ratio of 141.90.

Bausch Health Cos (NYSE:BHC - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.90 EPS for the quarter, missing analysts' consensus estimates of $0.97 by ($0.07). Bausch Health Cos had a negative return on equity of 852.36% and a net margin of 0.99%. The firm had revenue of $2.57 billion for the quarter, compared to analyst estimates of $2.47 billion. On average, equities research analysts predict that Bausch Health Cos Inc. will post 4.41 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of BHC. Cary Street Partners Financial LLC purchased a new position in shares of Bausch Health Cos in the 1st quarter valued at $27,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Bausch Health Cos during the first quarter worth $27,000. SBI Securities Co. Ltd. increased its stake in shares of Bausch Health Cos by 244.2% during the first quarter. SBI Securities Co. Ltd. now owns 4,230 shares of the company's stock worth $27,000 after acquiring an additional 3,001 shares during the period. Russell Investments Group Ltd. raised its stake in shares of Bausch Health Cos by 65.9% during the 2nd quarter. Russell Investments Group Ltd. now owns 7,819 shares of the company's stock worth $51,000 after buying an additional 3,106 shares in the last quarter. Finally, Wealthquest Corp acquired a new stake in Bausch Health Cos in the first quarter valued at $58,000. 78.65% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on BHC. Wall Street Zen upgraded Bausch Health Cos from a "hold" rating to a "buy" rating in a report on Saturday, August 2nd. Royal Bank Of Canada upped their price objective on shares of Bausch Health Cos from $8.50 to $10.00 and gave the company a "sector perform" rating in a report on Friday, May 2nd.

Bausch Health Cos Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.